Review
doi: 10.1016/0165-6147(92)90126-q.
Development of GPIIb/IIIa antagonists as antithrombotic drugs
Affiliations
- PMID: 1440877
- DOI: 10.1016/0165-6147(92)90126-q
Item in Clipboard
Review
Development of GPIIb/IIIa antagonists as antithrombotic drugs
Trends Pharmacol Sci.
1992 Nov.
Abstract
Thrombosis represents a major target for development of drugs to prevent and treat a variety of cardiovascular and cerebrovascular diseases, which are the leading cause of morbidity and mortality in the Western world. This review by Andy Nichols and colleagues focuses on a central process in thrombosis, namely platelet aggregation, and how it can be inhibited by antagonists of the adhesion molecule GPIIb/IIIa. Successful and future therapeutic applications of GPIIb/IIIa antagonists, and their pharmacology, are considered in detail.
Similar articles
-
Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.Blood. 1992 Sep 1;80(5):1247-53. Blood. 1992. PMID: 1515641
-
Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.Circulation. 1994 Jan;89(1):3-12. doi: 10.1161/01.cir.89.1.3. Circulation. 1994. PMID: 8281661
-
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.J Cardiovasc Pharmacol. 1997 Aug;30(2):261-72. doi: 10.1097/00005344-199708000-00017. J Cardiovasc Pharmacol. 1997. PMID: 9269956
-
Novel antithrombotic drugs in development.Drugs. 1995 Jun;49(6):856-84. doi: 10.2165/00003495-199549060-00002. Drugs. 1995. PMID: 7641602 Review.
-
Antithrombotic agents: from RGD to peptide mimetics.Bioorg Med Chem. 1995 Apr;3(4):337-60. doi: 10.1016/0968-0896(95)00036-g. Bioorg Med Chem. 1995. PMID: 8581417 Review.
Cited by
-
Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.J Comput Aided Mol Des. 1994 Dec;8(6):709-30. doi: 10.1007/BF00124017. J Comput Aided Mol Des. 1994. PMID: 7738606
-
Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.Biochem J. 1994 Aug 1;301 ( Pt 3)(Pt 3):785-91. doi: 10.1042/bj3010785. Biochem J. 1994. PMID: 7519850 Free PMC article.
-
Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species.Biochem J. 1995 Jan 15;305 ( Pt 2)(Pt 2):513-20. doi: 10.1042/bj3050513. Biochem J. 1995. PMID: 7832768 Free PMC article.
-
Antiplatelet drugs. A comparative review.Drugs. 1995 Jul;50(1):7-28. doi: 10.2165/00003495-199550010-00002. Drugs. 1995. PMID: 7588091 Review.
-
Molecular cloning and expression of catrocollastatin, a snake-venom protein from Crotalus atrox (western diamondback rattlesnake) which inhibits platelet adhesion to collagen.Biochem J. 1995 Apr 15;307 ( Pt 2)(Pt 2):411-7. doi: 10.1042/bj3070411. Biochem J. 1995. PMID: 7733877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
